clinical trial · NCT06624072
A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food
Boehringer Ingelheim·phase1·completed·n = 15
HealthyNerandomilast 18 mg - adult formulationNerandomilast 1 mg - paediatric formulation
brief summary
The main objective of this trial is to investigate two different formulations of nerandomilast and the effect of food on the pharmacokinetics of the new formulation following oral administration.
started
Oct 15, 2024
primary completion
Nov 22, 2024
completion
Nov 30, 2024
last updated
Jan 8, 2026
official title
Relative Bioavailability of Two Different Formulations of Nerandomilast and Investigation of the Food Effect on New Formulation Following Oral Administration in Healthy Adult Male and Female Subjects (an Open-label, Randomised, Single-dose, Three-way Crossover Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol